City Protocol Virality Leaderboard goes live, with the first $20,000 prize pool now open
BlockBeats News, February 27, according to official sources, Base ecosystem's attention infrastructure protocol City Protocol has officially launched the Virality Leaderboard—a creator leaderboard that uses AI to evaluate Mindshare in real time and settle rewards. The first round of the CP prize pool, equivalent to $20,000, is now open.
It is worth noting that the leaderboard is architecturally designed as an open reward distribution layer: in the future, any project within the Base ecosystem can connect its own tokens and airdrop budgets to the leaderboard. This means that early-established rankings and Mindshare records may continue to capture rewards from multiple projects.
The current point acquisition efficiency may be at a historical high. Users can enter the leaderboard by completing three tasks on the City Rewards page within the Base App.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Intel Confirms Advancement of Musk's "Terafab" Chip Plan Amid Stock Price Pressure
Intel CEO Pat Gelsinger stated that the company will continue to participate in Elon Musk's Terafab project. Previously, Musk revealed ongoing discussions with TSMC about potential collaboration, which raised market concerns over Intel's position in the project. As a result, Intel's stock price once dropped by 3.9%.
Gold Price Forecast: XAU/USD retraces gains and nears two-month lows at $4,104
BUZZ-Caribou shares plunge as company explores sale and cancels cancer project
October 7 - ** Caribou Biosciences (CRBU.O) shares fell 35.9% in pre-market trading to $0.72 ** Caribou Biosciences announced late Tuesday that it is exploring strategic options, including a potential sale, merger, or other transactions, to maximize shareholder value ** Caribou said it plans to halt development of its allogeneic CAR-T cell therapy programs, including vispa-cel for non-Hodgkin lymphoma and CB-011 for multiple myeloma ** Caribou also stated it will lay off employees and cut costs, with most layoffs expected to be completed by Q4 2026 ** As of June 30, the company held $113.8 millions in cash, cash equivalents, and marketable securities ** As of the previous trading day's close, the company's share price had dropped about 28% year-to-date (Note: For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only for reader convenience. Reuters assumes no responsibility for any damages or losses resulting from the use of automated translation features.)
